What happened
Genomictree reported consolidated results for FY2025: revenue of US$2.57M (+59.1% year on year), an operating loss of US$7.86M and a net loss of US$6.37M.
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$2.57M |
|---|---|
| Revenue vs a year earlier | +59.1% |
| Operating profit | −US$7.86M |
| Net income | −US$6.37M |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-09, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260209901336 → open original filing |
Source: DART. Information only, not investment advice.